HUM - Humana Inc.

Price: -- -- | CONSENSUS: Hold DETAILS | PRICE TARGET: $343.06 DETAILS

Stock News

Nomura Core Equity Fund Q2 2026 Portfolio Review

Seagate Technology shares continued to advance as demand for high-capacity storage tied to AI data-center buildouts supported further positive earnings revisions. On balance, the Fund's artificial intelligence positioning was a net positive contributor to relative performance during the quarter. We added the Humana position on the view that earnings are at a cyclical trough, with MA margins currently depressed, in some cases negative, as elevated medical cost trends have outpaced premium growth across the industry.

Jul 22, 2026 08:35 AM • seekingalpha.com

Humana (HUM) Expected to Beat Earnings Estimates: Should You Buy?

Humana (HUM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Jul 22, 2026 07:01 AM • zacks.com

Humana Inc. $HUM Shares Sold by California Public Employees Retirement System

California Public Employees Retirement System reduced its holdings in shares of Humana Inc. (NYSE: HUM) by 24.4% during the undefined quarter, according to its most recent 13F filing with the SEC. The fund owned 171,183 shares of the insurance provider's stock after selling 55,174 shares during the period. California Public Employees Retirement System

Jul 21, 2026 11:45 PM • defenseworld.net

Humana (HUM) is a Great Momentum Stock: Should You Buy?

Does Humana (HUM) have what it takes to be a top stock pick for momentum investors? Let's find out.

Jul 21, 2026 09:01 AM • zacks.com

Is Humana (HUM) Stock Outpacing Its Medical Peers This Year?

Here is how Humana (HUM) and Envoy Medical, Inc. (COCH) have performed compared to their sector so far this year.

Jul 17, 2026 06:46 AM • zacks.com

Can Humana (HUM) Run Higher on Rising Earnings Estimates?

Humana (HUM) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Jul 16, 2026 09:21 AM • zacks.com

Medicare's $50 Weight-Loss Drug Window Opens In July: What Smart Enrollees Do Before 2027

A weight-loss prescription that runs $149 to $449 a month at the pharmacy counter now costs some Medicare enrollees $50. Across a year, that is the difference between roughly $600 and more than $4,000, and whether you capture the savings depends on a coverage question most people do not realize they are answering.

Jul 16, 2026 05:16 AM • benzinga.com

Humana Eyes 3% Medicare Advantage Margin: Can It Deliver?

Humana targets a 3% Medicare Advantage margin by 2028 while pursuing 25% 2026 membership growth and rebuilding profitability despite industry headwinds.

Jul 13, 2026 09:40 AM • zacks.com

Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK, July 3, 2026

Jul 03, 2026 09:00 AM • gurufocus.com

Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

Jul 03, 2026 08:49 AM • prnewswire.com

The Humana Foundation Deepens Investment in Emotional Health, Announcing Over $12 Million in New Grants

LOUISVILLE, Ky.--(BUSINESS WIRE)--The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM) for the past 45 years, today announced its first slate of 2026 grants, dedicating over $12.2 million to programs and research focused on emotional well-being. The funding will support 13 nonprofit organizations and five university research teams focused on combating loneliness, depression and social isolation among seniors and veterans nationwide. The 2026 national grants scale the Foundati.

Jun 30, 2026 04:00 AM • businesswire.com

Dario Appoints Former Humana Chief Compliance Officer Sean O'Reilly to Advisory Board to Support Strategic Growth and Healthcare Partnerships

O'Reilly's extensive experience across healthcare compliance, risk management, regulatory oversight and payer operations expected to support Dario's continued expansion with health plans, employers and providers as Dario moves closer to care O'Reilly's track record of leveraging advanced data analytics and AI in supporting value-based care strongly aligned with Dario's AI transition NEW YORK, June 30, 2026 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (the "Company", "DarioHealth" or "Dario"), a leader in AI-enabled digital health solutions, today announced the appointment of Sean O'Reilly to its Advisory Board. The appointment reflects Dario's continued focus on strengthening its strategic guidance as the Company advances its channel partner-led growth strategy and moves closer to care across the payer, provider and employer markets.

Jun 30, 2026 03:30 AM • prnewswire.com

How CenterWell Is Driving Humana's Growth Beyond Insurance

CenterWell's rapid growth is helping HUM expand beyond insurance with integrated care, acquisitions, AI and a 2026 revenue target of at least $25B.

Jun 29, 2026 07:45 AM • zacks.com

Swedish care provider Ambea makes recommended $304 million offer for Humana

Swedish care provider Ambea said on Monday it had made a recommended public offer for peer Humana , valuing the ‌company at about 2.96 billion Swedish crowns ($304.13 million).

Jun 28, 2026 09:56 PM • reuters.com

Can Humana's Margin Recovery Drive Long-Term Earnings Growth?

HUM is shifting from membership growth to profitability, with lower medical costs, rising CenterWell revenues, and a margin recovery plan through 2028.

Jun 24, 2026 08:25 AM • zacks.com

Humana Inc. (NYSE: HUM) Investor Alert: Schubert Jonckheer Investigating Possible False Statements Regarding Healthcare Utilization Costs, Over $104 Million Insider Sales

Humana Inc. (NYSE: HUM) Investor Alert: Schubert Jonckheer Investigating Possible False Statements Regarding Healthcare Utilization Costs, Over

Jun 23, 2026 09:00 AM • gurufocus.com (Hide legal announcements)

Humana Inc. (NYSE: HUM) Investor Alert: Schubert Jonckheer Investigating Possible False Statements Regarding Healthcare Utilization Costs, Over $104 Million Insider Sales

SAN FRANCISCO, June 23, 2026 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP advises Humana Inc. (NYSE: HUM) investors that the firm is investigating potential legal claims arising from alleged false and misleading statements about the company's exposure to increased healthcare utilization costs. Current shareholders are encouraged to contact the firm here: https://www.classactionlawyers.com/humana.

Jun 23, 2026 08:00 AM • prnewswire.com (Hide legal announcements)

Humana Inc. to Release Second Quarter 2026 Results on July 29, 2026

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) will release its financial results for the second quarter 2026 (2Q26), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on July 29, 2026. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2026. A webcast of the 2Q26 earnings call may be accessed via Humana's Investor Relations page at h.

Jun 22, 2026 12:30 PM • businesswire.com

UnitedHealth vs. Humana: Which Healthcare Leader Is a Better Bet Now?

UNH's diversified platform, AI investments and stronger earnings outlook give it an edge over Medicare-focused rival HUM.

Jun 22, 2026 09:55 AM • zacks.com

3 Stocks Doing the Heavy Lifting in Healthcare's Rebound

Until recently, it had been a lackluster year for the healthcare sector. From high medical utilization squeezing insurers to structural cost pressures and valuation hangovers, medical stocks stocks have lagged much of the broader market this year.

Jun 18, 2026 05:31 AM • marketbeat.com